Versigent (NYSE:VGNT) Now Covered by Analysts at Evercore

Evercore initiated coverage on shares of Versigent (NYSE:VGNTFree Report) in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $55.00 price objective on the stock.

Other equities analysts have also recently issued reports about the stock. Fox Advisors raised shares of Versigent to a “strong-buy” rating in a report on Tuesday, April 7th. Wall Street Zen raised shares of Versigent to a “hold” rating in a report on Saturday. Royal Bank Of Canada assumed coverage on shares of Versigent in a report on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 target price on the stock. Wells Fargo & Company assumed coverage on shares of Versigent in a report on Monday, April 6th. They issued an “overweight” rating and a $35.00 target price on the stock. Finally, UBS Group assumed coverage on shares of Versigent in a report on Tuesday, April 14th. They issued a “buy” rating and a $43.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $41.60.

Check Out Our Latest Research Report on Versigent

Versigent Price Performance

Shares of Versigent stock opened at $35.11 on Tuesday. Versigent has a 12 month low of $26.34 and a 12 month high of $36.87.

Further Reading

Analyst Recommendations for Versigent (NYSE:VGNT)

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.